ArriVent BioPharma, Inc. AVBP Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s change in other assets?
- ArriVent BioPharma, Inc. (AVBP) reported change in other assets of $2.56M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s change in other assets changed year-over-year?
- ArriVent BioPharma, Inc.'s change in other assets increased by 61.0% year-over-year, from $1.59M to $2.56M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s change in other assets?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s change in other assets has grown at a 15.2% compound annual growth rate (CAGR), from -$9.67M to $12.84M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.